BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 626717)

  • 1. Lymphocytotoxicity in mycosis fungoides.
    Price NM; Mirkovich AM
    Br J Dermatol; 1978 Jan; 98(1):97-102. PubMed ID: 626717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cytotoxic effect of the thrombocytes from patients with mycosis fungoides and Kaposi's sarcoma].
    Faradzhev ZG; Bolvacheva AV; Bykovskaia SN
    Vestn Dermatol Venerol; 1990; (11):34-6. PubMed ID: 2288150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides.
    Kragballe K; Herlin T; Ellegaard J
    Arch Dermatol; 1983 Mar; 119(3):203-6. PubMed ID: 6824357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotype of lymphocytic infiltrate in mycosis fungoides at the plaque stage and at the tumor stage. A comparative study].
    Cerroni L; Peris K; Torlone G; Chimenti S
    G Ital Dermatol Venereol; 1990 Aug; 125(7-8):313-7. PubMed ID: 2289812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte abnormalities in mycosis fungoides.
    MacKie R; Sless FR; Cochran R; De Sousa M
    Br J Dermatol; 1976 Feb; 94(2):173-8. PubMed ID: 1082769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification in situ of T lymphocytes in the dermal and epidermal infiltrates of mycosis fungoides.
    Chu AC; MacDonald DM
    Br J Dermatol; 1979 Feb; 100(2):177-82. PubMed ID: 371659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycosis fungoides following skin trauma.
    Paul LJ; Duvic M
    J Am Acad Dermatol; 2012 Oct; 67(4):e148. PubMed ID: 22980272
    [No Abstract]   [Full Text] [Related]  

  • 8. In situ identification and enumeration of T lymphocytes in cutaneous T-cell lymphomas by demonstration of granular activity of acid non-specific esterase.
    Sterry W; Steigleder GK; Pullmann H
    Br J Dermatol; 1980 Jul; 103(1):67-72. PubMed ID: 6968580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell population in the cutaneous infiltrate of mycosis fungoides: in situ using monoclonal antisera.
    Holden CA; Morgan EW; MacDonald DM
    Br J Dermatol; 1982 Apr; 106(4):385-92. PubMed ID: 6462163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serum of mycosis fungoides patients on lymphocyte transformation.
    Kinoshita M; Kawada A
    J Dermatol; 1976 Aug; 3(4):115-9. PubMed ID: 15633964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alternations of dermal lymphocytes in mycosis fungoides, a study with the scanning electron microscope (author's transl)].
    Sterry W; Schulze HJ; Steigleder GK
    Z Hautkr; 1981 Apr; 56(8):498-508. PubMed ID: 7245821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basaloid folliculolymphoid hyperplasia: a distinctive finding in follicular mycosis fungoides.
    Gerami P; Guitart J
    J Cutan Pathol; 2007 Dec; 34 Suppl 1():29-32. PubMed ID: 17997735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed lymphokine activated killer cell activity in mycosis fungoides. A possible marker for aggressive disease.
    Wood NL; Kitces EN; Blaylock WK
    Arch Dermatol; 1990 Jul; 126(7):907-13. PubMed ID: 2360838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HECA-452 in parapsoriasis and mycosis fungoides.
    Di Trolio R; Di Lorenzo G; Barbiero E; Iacono A; Franco R; D Armiento M; Delfino M; D Armiento FP
    Int J Immunopathol Pharmacol; 2006; 19(1):105-10. PubMed ID: 16569348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
    Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
    Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides.
    Mackie RM; Turbitt ML
    Br J Dermatol; 1982 Apr; 106(4):379-84. PubMed ID: 6462162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mycosis fungoides an "immunoma'?
    Schuppli R
    Dermatologica; 1976; 153(1):1-6. PubMed ID: 791714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of HLA antigens in patients with mycosis fungoides.
    Dick HM; Mackie R
    Dermatologica; 1977; 155(5):275-82. PubMed ID: 902838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death due to splenic rupture in suppressor cell mycosis fungoides: a case report.
    Bennett SR; Greer JP; Stein RS; Glick AD; Cousar JB; Collins RD
    Am J Clin Pathol; 1984 Jul; 82(1):104-9. PubMed ID: 6234792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides.
    Kallinich T; Muche JM; Qin S; Sterry W; Audring H; Kroczek RA
    J Invest Dermatol; 2003 Nov; 121(5):1045-52. PubMed ID: 14708605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.